{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:07:38Z","timestamp":1791353258012,"version":"4.3.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.gore.2024.101353","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T04:41:21Z","timestamp":1709095281000},"page":"101353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sertoli-Leydig cell tumor with DICER1 mutation"],"prefix":"10.1016","volume":"52","author":[{"given":"Shae N.","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Landrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gore.2024.101353_b0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10689-021-00264-y","article-title":"Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group","volume":"20","author":"Bakhuizen","year":"2021","journal-title":"Fam Cancer."},{"issue":"9","key":"10.1016\/j.gore.2024.101353_b0010","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/PAS.0000000000000895","article-title":"DICER1 Mutations Are Consistenntly Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors","volume":"41","author":"de Kock","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.gore.2024.101353_b0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3349\/ymj.2021.62.4.366","article-title":"Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs","volume":"62","author":"Eoh","year":"2021","journal-title":"Yonsei Med. J."},{"issue":"3","key":"10.1016\/j.gore.2024.101353_b0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3747\/co.26.4727","article-title":"A family with Sertoli-Leydig cell tumour, multinodular goiter, and DICER1 mutation","volume":"26","author":"Haley","year":"2019","journal-title":"Curr. Oncol."},{"issue":"5","key":"10.1016\/j.gore.2024.101353_b0025","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/PAS.0000000000001232","article-title":"DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Overian Sertoli-Leydig Cell Tumors","volume":"43","author":"Karnezis","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.gore.2024.101353_b0030","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/diagnostics13061080","article-title":"Therapeutic Management and Prognostic Factors for Ovarian Malignant Tumors in Adolescents: A Comprehensive Review of Current Guidelines","volume":"13","author":"Margioula-Siarkou","year":"2023","journal-title":"Diagnostics."},{"key":"10.1016\/j.gore.2024.101353_b0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejogrb.2021.06.036","article-title":"Ovarian Sertoli-Leydig cell tumours: A systematic review of relapsed cases","volume":"263","author":"Nef","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.gore.2024.101353_b0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/CCO.0000000000000860","article-title":"Use of staging for sex cord stromal tumours","volume":"34","author":"Negri","year":"2022","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.gore.2024.101353_b0045","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer Including Fallopian Tube and Primary Peritoneal Cancer. 2024. p. MS-9-MS-12."},{"issue":"5","key":"10.1016\/j.gore.2024.101353_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10050143","article-title":"DICER1 Syndrome: DICER1 Mutations in Rare Cancers","volume":"10","author":"Robertson","year":"2018","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.gore.2024.101353_b0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2017.09.034","article-title":"DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry","volume":"147","author":"Schultz","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.gore.2024.101353_b0060","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1158\/1078-0432.CCR-17-0629","article-title":"PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","volume":"23","author":"Schultz","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.gore.2024.101353_b0065","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","article-title":"DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies","volume":"24","author":"Schultz","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.gore.2024.101353_b0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1159\/000508532","article-title":"Sertoli-Leydig Cell Ovarian Tumors: Is Fertility or Endocrine-Sparing Surgery an Option upon Relapse?","volume":"13","author":"Seidler","year":"2020","journal-title":"Case Rep. Oncol."},{"issue":"8","key":"10.1016\/j.gore.2024.101353_b0075","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2018.78.4678","article-title":"Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1","volume":"37","author":"Stewart","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.gore.2024.101353_b0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13048-021-00909-7","article-title":"Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients","volume":"14","author":"Wang","year":"2021","journal-title":"J. Ovar. Res."},{"issue":"8","key":"10.1016\/j.gore.2024.101353_b0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-198508000-00001","article-title":"Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases","volume":"9","author":"Young","year":"1985","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:59:20Z","timestamp":1762480760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578924000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":17,"alternative-id":["S2352578924000328"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2024.101353","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sertoli-Leydig cell tumor with DICER1 mutation","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2024.101353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101353"}}